{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:00:49Z","timestamp":1769749249625,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mvr.2021.104226","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T04:21:48Z","timestamp":1625804508000},"page":"104226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Thrombotic microangiopathy during pregnancy"],"prefix":"10.1016","volume":"138","author":[{"given":"Sepideh","family":"Zununi Vahed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalda","family":"Rahbar Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2021.104226_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0301-2115(02)00352-4","article-title":"Pathogenesis of acute renal failure associated with the HELLP syndrome: a case report and review of the literature","volume":"108","author":"Abraham","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mvr.2021.104226_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.ackd.2020.01.002","article-title":"Complement-mediated disorders in pregnancy","volume":"27","author":"Amari Chinchilla","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"1","key":"10.1016\/j.mvr.2021.104226_bb0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.kint.2020.10.046","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome na\u00efve to complement inhibitor treatment","volume":"100","author":"Ariceta","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2021.104226_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2020.08.038","article-title":"Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome","volume":"196","author":"Bazzan","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.mvr.2021.104226_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molimm.2015.06.021","article-title":"Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome","volume":"67","author":"Bernab\u00e9u-Herrero","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mvr.2021.104226_bb0030","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1074\/jbc.M114.630871","article-title":"The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease","volume":"290","author":"Bhattacharjee","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2021.104226_bb0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.mvr.2021.104226_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2018.38.2.95","article-title":"Evaluation of sFlt-1\/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center","volume":"38","author":"Caillon","year":"2018","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0055","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.imbio.2015.05.015","article-title":"Complement genetics and susceptibility to inflammatory disease. Lessons from genotype-phenotype correlations","volume":"221","author":"de C\u00f3rdoba","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.mvr.2021.104226_bb0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies","volume":"12","author":"Durey","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228709","article-title":"Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia\/HELLP syndrome","volume":"12","author":"Elabd","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.mvr.2021.104226_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy-related thrombotic microangiopathies: clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.mvr.2021.104226_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0085","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0090","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.2005.00362.x","article-title":"Preeclampsia: the death of goliath","volume":"55","author":"Feinberg","year":"2006","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.mvr.2021.104226_bb0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12882-020-02190-0","article-title":"Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis","volume":"22","author":"G\u00e4ckler","year":"2021","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0110","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI136094","article-title":"Complementopathies and precision medicine","volume":"130","author":"Gavriilaki","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2021.104226_bb0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","article-title":"TTP: long-term outcomes following recovery","volume":"2018","author":"George","year":"2018","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.mvr.2021.104226_bb0120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/asheducation-2015.1.644","article-title":"Syndromes of thrombotic microangiopathy associated with pregnancy","volume":"2015","author":"George","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.mvr.2021.104226_bb0125","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ket167","article-title":"Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases","volume":"52","author":"Hanouna","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mvr.2021.104226_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.9408","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mvr.2021.104226_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2215\/CJN.01260212","article-title":"Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome","volume":"8","author":"Hofer","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.kint.2017.06.022","article-title":"A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome","volume":"93","author":"Huerta","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2021.104226_bb0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17474086.2019.1611423","article-title":"An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura","volume":"12","author":"Joly","year":"2019","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.mvr.2021.104226_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preghy.2020.09.007","article-title":"Role of sFlt-1\/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with pre-eclampsia or HELLP syndrome","volume":"22","author":"Karge","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.mvr.2021.104226_bb0155","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0160","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0165","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ajg.2017.54","article-title":"Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management","volume":"112","author":"Liu","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.mvr.2021.104226_bb0175","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2020.00548","article-title":"Eculizumab treatment for postpartum HELLP syndrome and aHUS-case report","volume":"11","author":"Lokki","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mvr.2021.104226_bb0180","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.mvr.2021.104226_bb0185","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0190","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopha.2018.10.082","article-title":"Preeclampsia: a close look at renal dysfunction","volume":"109","author":"Moghaddas Sani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mvr.2021.104226_bb0195","first-page":"1","article-title":"Successful treatment of thrombotic thrombocytopenic purpura during pregnancy: a case report","volume":"4","author":"Naghshineh","year":"2017","journal-title":"J. Basic Res. Med. Sci."},{"key":"10.1016\/j.mvr.2021.104226_bb0200","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100638","article-title":"Thrombocytopenia in pregnancy: diagnosis and approach to management","volume":"40","author":"Pishko","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.mvr.2021.104226_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bjh.12494","article-title":"ADAMTS13 deficiency in severe postpartum HELLP syndrome","volume":"163","author":"Pourrat","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mvr.2021.104226_bb0220","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.AOG.0000215994.25958.31","article-title":"Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy","volume":"108","author":"Rehberg","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2021.104226_bb0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mvr.2021.104226_bb0230","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome na\u00efve to complement inhibitor treatment","volume":"97","author":"Rondeau","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2021.104226_bb0235","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/jth.15064","article-title":"Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura","volume":"18","author":"Sakai","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"28","key":"10.1016\/j.mvr.2021.104226_bb0240","first-page":"e1","article-title":"Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy","volume":"197","author":"Salahuddin","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2021.104226_bb0245","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1160\/TH03-11-0683","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women","volume":"92","author":"S\u00e1nchez-Luceros","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.mvr.2021.104226_bb0250","first-page":"211","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood","volume":"124","author":"Scully","year":"2014","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.mvr.2021.104226_bb0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10641955.2013.806538","volume":"32","author":"Simsek","year":"2013","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.mvr.2021.104226_bb0265","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2021.104226_bb0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-03051-2","article-title":"Congenital thrombotic thrombocytopenic purpura (TTP) with placental abruption despite maternal improvement: a case report","volume":"20","author":"Soffer","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.mvr.2021.104226_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/aji.12404","article-title":"Overactivation of complement alternative pathway in postpartum atypical hemolytic uremic syndrome patients with renal involvement","volume":"74","author":"Song","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.mvr.2021.104226_bb0280","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2011.152","article-title":"Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome","volume":"80","author":"Strobel","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.mvr.2021.104226_bb0285","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-020-04774-2","article-title":"The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab","volume":"36","author":"Tanaka","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0290","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.molimm.2007.09.008","article-title":"Role of complement and complement regulators in the removal of apoptotic cells","volume":"45","author":"Trouw","year":"2008","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.mvr.2021.104226_bb0295","article-title":"ADAMTS13 gene; a novel splicing site mutation in a case with thrombotic thrombocytopenic purpura","volume":"10","author":"Vahed","year":"2021","journal-title":"J. Nephropharmacol."},{"key":"10.1016\/j.mvr.2021.104226_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"Vaisbuch","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mvr.2021.104226_bb0305","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.mvr.2021.104226_bb0310","first-page":"3","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.mvr.2021.104226_bb0315","first-page":"1","article-title":"A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway","author":"Vaught","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0320","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0325","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2174\/1389201019666180712115215","article-title":"HELLP syndrome: pathophysiology and current therapies","volume":"19","author":"Wallace","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.mvr.2021.104226_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/JME-20-0308","article-title":"Inhibiting PDGF-D alleviates the symptoms of HELLP by suppressing NF-\u03baB activation","volume":"66","author":"Wang","year":"2021","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mvr.2021.104226_bb0335","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00467-018-4186-x","article-title":"Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0340","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejogrb.2021.02.027","article-title":"Therapeutic plasma exchange in pregnancy: a literature review","volume":"260","author":"Wind","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mvr.2021.104226_bb0345","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood-2018-99-110827","article-title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH)","volume":"132","author":"Wong","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104226_bb0350","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2010020167","article-title":"Bevacizumab increases risk for severe proteinuria in cancer patients","volume":"21","author":"Wu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mvr.2021.104226_bb0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/CH-200970","article-title":"Frequent recurrence of pregnancy-triggered congenital thrombotic thrombocytopenic purpura: a rare case report","volume":"77","author":"Xu","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.mvr.2021.104226_bb0360","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3324\/haematol.2016.153312","article-title":"Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"102","author":"Yuan","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.mvr.2021.104226_bb0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2021.104226_bb0370","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.kint.2020.05.028","article-title":"Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome","volume":"98","author":"Zhang","year":"2020","journal-title":"Kidney Int."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:00:36Z","timestamp":1758434436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286221000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":74,"alternative-id":["S0026286221000960"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104226","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic microangiopathy during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104226"}}